Featured in: Featured
Virginia passes law forcing physicians to disclose the limitations of tests
Va. now must disclose the flaws in Lyme disease testing Tuesday, February 26, 2013 BY MARKUS SCHMIDT Richmond Times-Dispatch Lyme disease is one of the fastest-growing infectious diseases in the United States, but despite testing, many patients are not aware that they are infected until it is too late. New legislation passed by Virginia’s General Assembly is supposed to change Continues →-
Corruption and Human Rights Violations Against Lyme Doctors, Scientists and Parents Now on United Nations Record
The 2018 Report ‘The Situation of the Human Rights Defenders of Lyme and Relapsing Fever Continues → -
A home for patient-oriented research
[CanLyme Note: On the Lyme disease file in Canada the patient has been rejected, removed, and Continues → -
“She looked like a stroke victim”
[CanLyme Note: How is it that physicians are so under-educated and misinformed on this disease Continues → -
Lawsuit: Insurance companies conspiring with physician members of the Infectious Diseases Society of America
November 19th, 2017 Lynne LaRowe Texackana Gazette Major health insurance companies are accused Continues →
Recent in: Featured
Prof. Christian Perronne, MD, PhD, outlines his history and the history of resistance within mainstream medicine regarding Lyme disease.
Christian Perronne, MD, PhD, is Professor of Infectious and Tropical Diseases at the Faculty of Medicine Paris-Ile de France-Ouest, University of Versailles-St Quentin en Yvelines (UVSQ), Paris-Saclay, France. He is chief of a Department of Medicine at the Raymond Poincaré University Hospital in Garches (Hauts-de-Seine), belonging to Assistance Publique – Hôpitaux de Paris, the Greater Paris University Hospitals. My fight Continues →
Unprecedented claim against the CDC over Lyme tests
August 23, 2017 written by Huib In the USA an unprecedented anti-trust law suit of $57 million is being prepared against the CDC. They are accused of deliberately suppressing the use of an accurate DNA direct diagnostics for Lyme disease. You can read about the aim and potential impact of this lawsuit in this article. “In the current situation, even in Continues →
Listen to today’s testimony of Dr. Ralph Hawkins, Dr. Liz Zubek, Canadian Blood Services and the Public Health Agency of Canada in the standing health committee.
June 8th, 2017 You can listen to the interesting testimony here… Dr. Njoo from the Public Health Agency of Canada believes patients are too stupid to be equal partners in setting guidelines on diagnostics and treatment. Only his buddies at AMMI, IDSA and the US CDC are qualified to have the final say… the same group who have failed us Continues →
New York Times: More Than 80 Percent of Patient Groups Accept Drug Industry Funds, Study Shows
[CanLyme Note: We have been approached by various pharma industry to work with them but we have steadfastly refused in order to maintain our independence, so as to not be beholding to the for-profit industry. Now if government and the Canadian medical associations and societies could shake their relationship with big-pharma then perhaps better health care would result.] March 2nd, 2017 Continues →
Canadian tax payer funded Lyme research not good value for dollar
In December of 2016 a Canadian article was published in PLOS ONE proporting itself as a good systematic review about Lyme disease testing accuracy. CanLyme has been trying to work closely with government on the value of good science as good evidence yet once again the government of Canada has managed to publish low-quality material without any patient expert input into Continues →
Medical community failing Lyme patients, Calgary doctor says
Elizabeth Payne, Ottawa Citizien, May 16th, 2016 Canada’s medical establishment came under pressure at a national conference into Lyme disease Monday, with a Calgary doctor suggesting treatment of some patients contravenes the Canadian Medical Association’s code of ethics. “We, as the medical community in Canada, are failing our patients,” said Dr. Ralph Hawkins, a Calgary physician who acknowledged his views Continues →
Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime
Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA http://dx.doi.org/10.3389/fmicb.2016.00062 10 February 2016 Lyme disease, caused by Borrelia burgdorferi, is the most common vector-borne disease in the United States and Europe. While the majority of Lyme disease patients can resolve their symptoms if treated promptly, 10–20% of patients suffer from prolonged symptoms Continues →
The Need for Clinical Judgment in the Diagnosis and Treatment of Lyme Disease
Abstract Clinical practice guidelines are increasing in number. Unfortunately, when scientific evidence is uncertain, limited, or evolving, as is often the case, conflict often arises between guideline committees and practicing physicians, who bear the direct responsibility for the care of individual patients. The 2006 Infectious Diseases Society of America guidelines for Lyme disease, which have limited scientific support, could, if Continues →
Unravelling the mystery of Lyme disease: Why Canada needs to do more
Rian Michelsen is a rising star. Fifteen years ago, he was the toddler who burst out from behind the curtains singing Elvis’ Viva Las Vegas. As a young boy, he played the lead role in Oliver in his birthplace of Bermuda, before moving with his family to Toronto five years ago. Now, as a 17 year-old high school student, he’s Continues →
In Test Tube, ‘Pulse-Doses’ Of Antibiotic Wipe Out Lyme Disease Bacteria Persisters
June 12, 2015 Carey Goldberg From the Northeast to the Midwest and beyond, it’s high season for Lyme disease. An estimated 300,000 Americans are diagnosed with the spreading, tickborne disease every year. Most can be successfully treated with antibiotics, but for some, symptoms persist for months and even years — pain, fatigue, arthritis. For me, Lyme disease news tends to Continues →
The association between infectious burden and Parkinson’s disease: A case-control study
Abstract Introduction The etiology of Parkinson’s disease (PD) remains unclear. The aim of this study was to examine the association between common pathogenic infections and PD. Methods Antibody titers to common infectious pathogens including cytomegalovirus (CMV), Epstein Barr virus (EBV), herpes simplex virus type-1 (HSV-1), Borrelia burgdorferi (B. burgdorferi), Chlamydophila pneumoniae (C. pneumoniae) andHelicobacter pylori (H. pylori) were measured by Continues →
Press Release: CROSS CANADA BIKE RIDE FOR LYME DISEASE
St. CATHARINES, ON – APRIL 15, 2015 – At sunrise on May 11, 2015, Niagara natives, 22 year old Daniel Corso and his long time friend Tanner Cookson will begin their 8000 km bike ride across Canada to bring awareness to, and raise money for, Lyme disease. The ride begins in Victoria, BC at the Terry Fox “Mile 0” mark Continues →
Penticton RCMP take the Lyme Sucks Challenge – Challenging all Canadian RCMP to follow their lead.
Published on Apr 8, 2015 PUCKER UP: RCMP members suck limes for a good cause Read article Watch video
Health Care Costs, Utilization and Patterns of Care following Lyme Disease [1.3 billion USD]
[CanLyme note: This study has limitations as noted therein and does not include cost of taxpayer funded disability income payments to the chronically ill, loss of taxable income from those who are unable to work, loss of productivity in the employment sector, along with other indirect costs to society and the taxpayer. It also does not reflect those infected with Continues →
Lyme and associated tick-borne diseases: global challenges in the context of a public health threat
Christian Perronne c.perronne@rpc.aphp.fr Lyme disease, caused by Borrelia burgdorferi and transmitted by ticks, was initially considered a recent, rare and regional occurrence. We now have evidence that very similar bacteria infected humans in Europe during the ice age (Keller et al.,2012). Evidence-based data are scarce therefore many aspects of the disease remain controversial (Auwaerter et al.,2011; Lee and Vielmeyer, 2011; Perronne,2012), but in 2013 the Centers Continues →